Baker Brothers Advisors - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 147 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2017$7,356,000
-14.3%
128,6660.0%0.06%
-8.6%
Q3 2017$8,588,000
+29.7%
128,6660.0%0.07%
+20.7%
Q2 2017$6,620,000
-11.9%
128,6660.0%0.06%
-4.9%
Q1 2017$7,514,000
+40.0%
128,6660.0%0.06%
+15.1%
Q4 2016$5,369,000
-51.1%
128,666
-38.1%
0.05%
-47.0%
Q3 2016$10,982,000
+26.1%
207,9150.0%0.10%
+9.9%
Q2 2016$8,711,000
-30.3%
207,915
-32.5%
0.09%
-31.1%
Q1 2016$12,501,000
+92.6%
307,915
+207.9%
0.13%
+144.4%
Q4 2015$6,492,000
-8.0%
100,0000.0%0.05%
-16.9%
Q3 2015$7,059,000
-36.5%
100,0000.0%0.06%
-33.0%
Q2 2015$11,114,000
-21.4%
100,000
-33.3%
0.10%
-17.8%
Q1 2015$14,141,000
-22.8%
149,954
-8.2%
0.12%
-36.9%
Q4 2014$18,307,000
+75.6%
163,393
-3.8%
0.19%
+42.7%
Q3 2014$10,423,000
+13.8%
169,893
-15.0%
0.13%
+17.0%
Q2 2014$9,159,000
+17.0%
199,8930.0%0.11%
+13.1%
Q1 2014$7,826,000
+58.8%
199,893
-2.8%
0.10%
+43.5%
Q4 2013$4,928,000
-11.9%
205,750
+2.9%
0.07%
-12.7%
Q3 2013$5,592,000200,0000.08%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Eagle Health Investments LP 431,413$12,558,0003.09%
Casdin Capital, LLC 2,090,000$60,840,0002.73%
Rock Springs Capital Management LP 2,665,275$77,586,0001.95%
Bellevue Group AG 4,129,292$120,204,0001.40%
SUVRETTA CAPITAL MANAGEMENT, LLC 1,177,374$34,273,0001.05%
Altium Capital Management LP 66,196$1,927,0000.64%
ArrowMark Colorado Holdings LLC 1,295,948$37,725,0000.33%
FARALLON CAPITAL MANAGEMENT LLC 1,333,012$38,804,0000.19%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 21,500$707,0000.16%
Virtus ETF Advisers LLC 11,541$336,0000.15%
View complete list of AGIOS PHARMACEUTICALS INC shareholders